Skip to main content
. Author manuscript; available in PMC: 2024 Mar 11.
Published in final edited form as: J Med Chem. 2021 May 18;64(10):6949–6971. doi: 10.1021/acs.jmedchem.1c00491

Figure 3.

Figure 3.

Dose–response curves (DRCs) of indicated inhibitors (A–E) against HDAC4 and (F–H) against HDAC8. Residual enzyme activity of HDAC4 or HDAC8 for compounds 7a–7m (I) and compounds 7n–7y (J) in the presence of 35 μM of the indicated compounds. Data represent means and standard deviations, n = 3. Compounds with less than 40% residual enzyme activity were taken further to determine IC50 values.